Rekha Hemrajani
Director/Board Member at MAXCYTE, INC.
Net worth: 50 610 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jaume Pons | M | 58 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 9 years |
| Maher Masoud | M | 49 | - | |
| Srini Akkaraju Akkaraju | M | 56 | 4 years | |
| Ron Holtz | M | 66 | 19 years | |
| Eric Morgen | M | - |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| Richard D. van Doren | M | 47 | 4 years | |
| Laurent Fischer | M | 60 | 4 years | |
| Graham Walmsley | M | 37 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 4 years |
| Peter García | M | 62 | 4 years | |
| Peter Soparkar | M | 53 | 5 years | |
| Kristen Fortney | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| Richard Douglas | M | 71 | 6 years | |
| Jason Lettmann | M | 46 | 4 years | |
| Dan Spiegelman | M | 65 | 4 years | |
| Steve Kelsey | M | 63 | 4 years | |
| Patrick Haley | M | 48 | 14 years | |
| Linda Kozick | F | 66 | 8 years | |
| Dawn Svoronos | F | 70 | 4 years | |
| Michael Giordano | M | 66 | 6 years | |
| Madhu Vikram Utamsingh | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
| Richard Rodgers | M | 57 | 9 years | |
| Alan Garber | M | 68 | 19 years | |
| Fred Eshelman | M | 76 | 4 years | |
| Scott Whitcup | M | 64 | 4 years | |
| Yasir Al-Wakeel | M | 42 | 3 years | |
| Sophia Randolph | M | 56 | 8 years | |
| Reed Tuckson | M | 73 | 3 years | |
| Douglas Swirsky | M | 54 | 1 years | |
| Mark Lupher | M | 53 | 5 years | |
| Heikki Jouttijärvi | M | - | 4 years | |
| Jack Wyszomierski | M | 68 | 20 years | |
| John Johnston | M | 65 | 8 years | |
| Jim Scopa | M | 65 | 5 years | |
| Art Mandell | M | 71 | 18 years | |
| George Poste | M | 79 | 20 years | |
| Stanley Erck | M | 76 | 19 years | |
| Will Brooke | M | 68 | 20 years | |
| Corey Goodman | M | 72 | 9 years | |
| Patrick Balthrop | M | 67 | 2 years | |
| Jason V. Coloma | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 years |
| Athanasios Tsiatis | M | - | 3 years | |
| Hank Stern | M | - | 9 years | |
| Hong I. Wan | M | - | 9 years | |
| Suresh Chandumal Vazirani | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
| Shelly Pinto | F | 48 | 3 years | |
| Bill Tan | M | - | 3 years | |
| Gene Zhu | M | - | - | |
| Jill Mayer | F | - | 6 years | |
| Dov Goldstein | M | 56 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 years |
| Chris Byrd | M | - | 2 years | |
| Dena House | F | - | 5 years | |
| Lisa Moore | M | - | 6 years | |
| Eric Matthews | M | - | 5 years | |
| Vijay Pande | M | 53 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| James Brady | M | - | - | |
| Laura Dillard | F | - | 19 years | |
| Thomas Ross | M | 63 | 10 years | |
| Dirk Brockstedt | M | 55 | 6 years | |
| Michael Chang | M | - | 9 years | |
| Robert J. Adelman | M | 61 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | - |
| Steven Nardi | M | - | 4 years | |
| J. Garland | M | 55 | 2 years | |
| Ali Soleymannezhad | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Cleveland | M | 67 | 4 years | |
| Jay Shepard | M | 65 | 7 years | |
| Doug Doerfler | M | 68 | 25 years | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Geoff Duyk | M | 64 | 7 years | |
| Christopher J. DeRespino | M | 43 | - | |
| Jason Barker | M | 54 | 1 years | |
| Jennifer Cheng | M | 51 | 4 years | |
| Jack Nielsen | M | 60 | 4 years | |
| Mohammed Malik | M | 56 | - | |
| James B. Bucher | M | 59 | 7 years | |
| Eric J. Hall | M | 69 | - | |
| Pamela Klein | M | 63 | - | |
| Cory Freedland | M | 48 | 2 years | |
| Angela Thedinga | F | 42 | 2 years | |
| Lori Friedman | M | 60 | - | |
| Myesha Lacy | F | - | - | |
| Jennifer Drimmer | F | - | 14 years | |
| Mitchell Finer | M | 65 | 13 years | |
| Robert Hoffman | M | 58 | 2 years | |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| J. Stark Thompson | M | 82 | 20 years | |
| Francis McCormick | M | 73 | 11 years | |
| Perry Karsen | M | 69 | 1 years | |
| Christoph Pereira | M | 51 | 3 years | |
| Carl Feldbaum | M | 80 | 16 years | |
| Eric Carter | M | 72 | 4 years | |
| Itziar Canamasas | M | 50 | 2 years | |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 years |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 years |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 years |
| Glen Y. Sato | M | 65 | 4 years | |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 years |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 years |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Michael Samar | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Carol Hoang | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 98.00% |
| India | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rekha Hemrajani
- Personal Network
